Institutional & Family Asset Management’s Immunic IMUX Stock Holding History

Institutional & Family Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30	Closed	-$1K	–	753
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	640
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	658
2022 Q1	$3K	Hold	30	–	–	﹤0.01%	614
2021 Q4	$3K	Hold	30	–	–	﹤0.01%	627
2021 Q3	$3K	Hold	30	–	–	﹤0.01%	739
2021 Q2	$4K	Hold	30	–	–	﹤0.01%	747
2021 Q1	$5K	Hold	30	–	–	﹤0.01%	686
2020 Q4	$5K	Hold	30	–	–	﹤0.01%	641
2020 Q3	$6K	Hold	30	–	–	﹤0.01%	560
2020 Q2	$4K	Hold	30	–	–	﹤0.01%	605
2020 Q1	$2K	Hold	30	–	–	﹤0.01%	653
2019 Q4	$3K	Hold	30	–	–	﹤0.01%	668
2019 Q3	$3K	Hold	30	–	–	﹤0.01%	634
2019 Q2	$3K	Hold	30	–	–	﹤0.01%	663
2019 Q1	$2K	Hold	30	–	–	﹤0.01%	721
2018 Q4	$2K	Hold	30	–	–	﹤0.01%	692
2018 Q3	$3K	Hold	30	–	–	﹤0.01%	683
2018 Q2	$81K	Hold	30	–	–	0.02%	304
2018 Q1	$81K	Hold	30	–	–	0.02%	278
2017 Q4	$71K	Hold	30	–	–	0.01%	167
2017 Q3	$60K	Hold	30	–	–	0.01%	174
2017 Q2	$34K	Buy	+30	New	+$40K	0.01%	126

Other funds holding IMUX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Institutional & Family Asset Management's IMUX Position: Q4 2022 in Review

Institutional & Family Asset Management sold out of Immunic (IMUX) in Q4 2022, closing a stake of 30 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in IMUX in Q2 2017 and held it in 22 quarters. The position peaked at $81K in Q2 2018. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

Institutional & Family Asset Management reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
Institutional & Family Asset Management sold 30 Immunic shares in Q4 2022, an estimated $1K.
Institutional & Family Asset Management first reported a position in Immunic in Q2 2017 and held it in 22 quarters.
Institutional & Family Asset Management's Immunic position peaked at $81K in Q2 2018.
58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Institutional & Family Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.